Guiabar, Norhima S.
HRN: 22-20-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/28/2023
01/30/2023
IV
500
Q8
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes